Robert Fekete is a Neurology physician affiliated with Westchester Medical Center. OpenAlex indexes 82 publications with 873 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
19 Bradhurst Ave
Suite 2850
Hawthorne, NY 105322140
Telephone
914-345-1313Provider last certified this registry record 19 Nov 2021.
Clinical trials
- Effect of Rasagiline on Balance in Parkinson's Disease as Measured by Computerized Posturography
Sponsor: New York Medical College
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
25 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Neurocrine BioSciences, Inc.Program year202520 payments$16,383openpaymentsdata.cms.gov ↗
- Teva Pharmaceuticals USA, Inc.Program year20252 payments
- ACADIA Pharmaceuticals IncProgram year202513 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
77.3%Neuromuscular Blocker77%Onabotulinumtoxina100%Part B, office-administered≥14 patientsgamma-Aminobutyric Acid-ergic Agonist0.4%Baclofen100%Part D<11 patientsNervous system
20.7%Aromatic Amino Acid Decarboxylation Inhibitor7.7%Carbidopa-Levodopa73%Carbidopa-Levodopa Er12%Rytary11%Carbidopa4%Part D≥141 patientsAtypical Antipsychotic1.5%Nuplazid49%Quetiapine Fumarate28%Olanzapine14%Risperidone10%Part D<11 patients+ 24 more classes in this area
Cardiovascular
1.7%Beta blocker1.6%Propranolol Hcl87%Propranolol Hcl Er13%Part D<11 patientsAdrenergic and dopaminergic agents0.1%Droxidopa100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Top motor and non-motor complaints in patients with Parkinson's disease
Frontiers in Aging Neuroscience
2025 - Head tremor in Parkinson´s Disease, clinical Associations and response to therapy
Clinical Parkinsonism & Related Disorders
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Stephan Mayer, MD
Westchester Medical Center
William Frishman, MD
Westchester Medical Center
Srihari Naidu, MD
Westchester Medical Center
Delong Liu, MD, PhD
Westchester Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”